Lung function decline from adolescence to young adulthood in cystic fibrosis
- 24 August 2011
- journal article
- research article
- Published by Wiley in Pediatric Pulmonology
- Vol. 47 (2), 135-143
- https://doi.org/10.1002/ppul.21526
Abstract
Background Despite improving survival in cystic fibrosis (CF) patients, there is a mortality peak in early adulthood. Defining risk factors that predict significant worsening of lung disease in young adulthood may identify opportunities to improve outcomes in adults. Methods We identified 4,680 patients in the Epidemiologic Study of Cystic Fibrosis 1994–2005 with data in both adolescence (age 14.0–17.4 years) and young adulthood (age 18.5–22.0 years) and analyzed 2,267 who had ≥5 encounters and ≥5 measurements of forced expiratory volume in 1 second (FEV1) spanning ≥1 year during both adolescence and young adulthood, and ≥1 encounter with weight and height and ≥1 FEV1 measurement age 17.5–18.5 years. We compared the annualized rates of decline in FEV1 during adolescence and young adulthood stratified by best FEV1 around age 18. Logistic regression was used to identify risk factors associated with substantial decline (>20 points) in FEV1% predicted in young adulthood. Results Annual rate of decline was greater in young adulthood than in adolescence. Risk factors for substantial decline included slower rate of FEV1 decline, greater FEV1 variability, faster body mass index (BMI) decline, male sex, chronic inhaled antibiotics, Haemophilus influenzae detection, and absence of multidrug-resistant Pseudomonas aeruginosa in adolescence, and lower than expected FEV1 and BMI around age 18. Conclusions Decline in lung function accelerates in young adults with CF, especially in those with early stage lung disease. Adolescents at risk for substantial decline in lung function in young adulthood have higher FEV1 and worse nutritional status, among other identifiable risk factors. Pediatr Pulmonol. 2012; 47:135–143.Keywords
This publication has 23 references indexed in Scilit:
- Clinical use of dornase alfa is associated with a slower rate of FEV1 decline in cystic fibrosisPediatric Pulmonology, 2011
- Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and MortalityDiabetes Care, 2009
- Relationship between Inhaled Corticosteroid Therapy and Rate of Lung Function Decline in Children with Cystic FibrosisThe Journal of Pediatrics, 2008
- Predictors of mortality in adults with cystic fibrosisPediatric Pulmonology, 2007
- Haemophilus influenzaeForms Biofilms on Airway EpitheliaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosisPediatric Pulmonology, 2002
- Wasting as an independent predictor of mortality in patients with cystic fibrosisThorax, 2001
- The self-image of adolescents with cystic fibrosisJournal of Adolescent Health, 1995
- Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosisPediatric Pulmonology, 1992